Advancement in lipid based nanoparticels for cancer treatment

Authors

  • Neeluru. Padmavathi Devi Priyadarshini Institute of Pharmaceutical Education and Research 5th Mile, Pulladigunta, Guntur-522017. Andhra Pradesh, India

Keywords:

Nanoparticle, Cancer Treatment, Lipid Based Drug Delivery, Cancer Cells

Abstract

This review evaluates the literature on nanoparticle-based drug delivery systems for cancer treatment and assesses their efficacy. Nanoparticles have shown potential for improving anticancer agent delivery, reducing systemic toxicity, and enhancing therapeutic outcomes. Extensive studies have shown promising results in preclinical and clinical trials. Therefore, a novel paradigm with concomitant imaging (with contrasting agents), targeting (with biomarkers), and anticancer agent being delivered in one lipidic nanocarrier system (as cancer theragnostic) seems to be very promising in overcoming various hurdles in effective cancer treatment. The major obstacles that are supposed to be addressed by employing lipidic theragnostic nanomedicine include nanomedicine reach to tumour cells, drug internalization in cancer cells for therapeutic intervention, off-site drug distribution, and uptake via the host immune system. A comprehensive account of recent research updates in the field of lipidic nanocarrier loaded with therapeutic and diagnostic agents is covered in the present article. Nevertheless, there are notable hurdles in the clinical translation of the lipidic theragnostic nanomedicines, which are also highlighted in the present review along with plausible countermeasures.

Downloads

Download data is not yet available.

References

Manjunath K, Reddy JS, Venkateswarlu V. Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol. 2005 Mar 1;27(2):127-44

Ekambaram P. a. Abdul hasan sathali and k. Priyanka; Solid lipid nanoparticles: a review; sci. Revs. Chem. Commun. 2012;2(1).

de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020). Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. The Lancet global health, 8(2), e180-e190.

Hansen AE, Petersen AL, Henriksen JR, Boerresen B, Rasmussen P, Elema DR, Rosenschöld PM, Kristensen AT, Kjær A, Andresen TL. Positron emission tomography based elucidation of the enhanced permeability and retention effect in dogs with cancer using copper-64 liposomes. ACS nano. 2015 Jul 28;9(7):6985-95. https://doi.org/10.1021/acsnano.5b01324

Qiao L, Yang H, Gao S, Li L, Fu X, Wei Q. Research progress on self-assembled nanodrug delivery systems. Journal of Materials Chemistry B. 2022;10(12):1908-22. https://doi.org/10.1039/D1TB02470A

Hwisa NT, Gindi S, Rao CB, Katakam P, Rao Chandu B. Evaluation of Antiulcer Activity of Picrasma Quassioides Bennett Aqueous Extract in Rodents. Vedic Res. Int. Phytomedicine. 2013;1:27.

https://doi.org/10.2174/157016311796799062

Gindi S, Methra T, Chandu BR, Boyina R, Dasari V. Antiurolithiatic and invitro anti-oxidant activity of leaves of Ageratum conyzoides in rat. World J. Pharm. Pharm. Sci. 2013 Feb 8;2:636-49.

https://doi.org/10.1016/j.jddst.2020.101880

Hu J, Fu S, Peng Q, Han Y, Xie J, Zan N, Chen Y, Fan J. Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: In vitro and in vivo evaluation. International journal of pharmaceutics.2017 Jan 10;516(1-2):313-22.

https://doi.org/10.1016/j.ijpharm.2016.11.047

Harrison PJ, Wieslander H, Sabirsh A, Karlsson J, Malmsjö V, Hellander A, Wählby C, Spjuth O. Deep-learning models for lipid nanoparticle-based drug delivery. Nanomedicine. 2021 Jun 1;16(13):1097-110.

https://doi.org/10.2217/nnm-2020-0461

Nama S, Chandu BR, Awen BZ, Khagga M. Development and validation of a new RP-HPLC method for the determination of aprepitant in solid dosage forms. Tropical Journal of Pharmaceutical Research. 2011;10(4):491-7.

https://doi.org/10.1016/j.cll.2012.01.001

Rompicharla, S. V`. K., Bhatt, H., Shah, A., Komanduri, N., Vijayasarathy, D., Ghosh, B., & Biswas, S. (2017). Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity. Chemistry and physics of lipids, 208, 10-18. https://doi.org/10.1016/j.chemphyslip.2017.08.009

Dara SR. An Overview of the Use of Natural Indicators in Acid-Base Titrations. UPI Journal of Pharmaceutical, Medical and Health Sciences. 2024 Jul 23:29-35.

Kiranmai M, Renuka P, Brahmaiah B, Chandu BR. Vitamin D as a promising anticancer agent.

Published

31-07-2025

How to Cite

Neeluru, P. D. (2025). Advancement in lipid based nanoparticels for cancer treatment. International Journal of Current Innovations in Advanced Research, 8(2), 29–33. Retrieved from https://ijciar.com/index.php/journal/article/view/203

Issue

Section

Review Articles